- [YEAR:23-12-1997]Thompson,S.K., Halbert,S.M., Bossard,M.J., Tomaszek,T.A., Levy,M.A., Zhao,B.G., Smith,W.W., bdel-Meguid,S.S., Janson,C.A., D'Alessio,K.J., McQueney,M.S., Amegadzie,B.Y., Hanning,C.R., DesJarlais,R.L., Briand,J., Sarkar,S.K., Huddleston,M.J., Ijames,C.F., Carr,S.A., Garnes,K.T., Shu,A., Heys,J.R., Bradbeer,J., Zembryki,D., Lee-Rykaczewski,L., James,I.E., Lark,M.W., Drake,F.H., Gowen,M., Gleason,J.G. and Veber,D.F. \<br\>Design of potent and selective human cathepsin K inhibitors that span the active site\<br\>Proc Natl Acad Sci U S A (23-12-1997) 94, 14249-14254. PubMed Europe PubMed DOI I
1997
